Denmark
  • Europe
    • FR
    • DE
    • IT
    • ES
    • PL
    • BE
    • NL
    • LU
    • CH
    • NO
    • SE
    • FI
    • EE
    • LV
    • LT
  • Denmark
    • Faroe Islands
    • Greenland
    • Copenhagen
  • Business
    • Mærsk
    • Novo Nordisk
    • DSV
    • Ørsted
    • Danske Bank
    • Vestas Wind Systems
    • LEGO
    • DFDS
  • Nordics
    • Stockholm
    • Oslo
    • Helsinki
  • Baltics
    • Tallinn
    • Riga
    • Vilnius
  • Benelux
    • Brussels
    • Amsterdam
  • Warsaw
  • Berlin
  • NATO
  • UK
  • US
  • Africa
  • Amsterdam
  • Berlin
  • Brussels
  • Copenhagen
  • Danske Bank
  • Denmark
  • DFDS
  • DSV
  • Faroe Islands
  • Greenland
  • Helsinki
  • LEGO
  • Mærsk
  • Novo Nordisk
  • Ørsted
  • Oslo
  • Riga
  • Stockholm
  • Tallinn
  • Vestas Wind Systems
  • Vilnius
  • Warsaw
Denmark
  • Europe
    • FR
    • DE
    • IT
    • ES
    • PL
    • BE
    • NL
    • LU
    • CH
    • NO
    • SE
    • FI
    • EE
    • LV
    • LT
  • Denmark
    • Faroe Islands
    • Greenland
    • Copenhagen
  • Business
    • Mærsk
    • Novo Nordisk
    • DSV
    • Ørsted
    • Danske Bank
    • Vestas Wind Systems
    • LEGO
    • DFDS
  • Nordics
    • Stockholm
    • Oslo
    • Helsinki
  • Baltics
    • Tallinn
    • Riga
    • Vilnius
  • Benelux
    • Brussels
    • Amsterdam
  • Warsaw
  • Berlin
  • NATO
  • UK
  • US
  • Africa

Browsing Tag

GuruFocus

23 posts
DDSV
DSV A/S Reports Strong Q3 Profit Growth, Shares Trade at 40% Dis
Read More

DSV A/S Reports Strong Q3 Profit Growth, Shares Trade at 40% Dis

  • 2026-10-27
On October 21, 2026, DSV A/S (OTCPK: DSDVF) announced a robust increase in its third-quarter net profit, alongside…
NNovo Nordisk
Huge News For Novo Nordisk Fans
Read More

Huge News For Novo Nordisk Fans

  • 2026-09-23
This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO) is considering hair loss as one possible area for…
NNovo Nordisk
Huge News For Novo Nordisk Fans
Read More

Huge News For Novo Nordisk Fans

  • 2026-09-23
This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO) is considering hair loss as one possible area for…
NNovo Nordisk
Novo Drops as Claude Enters Drug Development
Read More

Novo Drops as Claude Enters Drug Development

  • 2026-09-18
This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO), the diabetes-and-obesity pharmaceutical leader, brought Anthropic’s Claude into its…
NNovo Nordisk
Novo Drops as Claude Enters Drug Development
Read More

Novo Drops as Claude Enters Drug Development

  • 2026-09-16
This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO), the diabetes-and-obesity pharmaceutical leader, brought Anthropic’s Claude into its…
NNovo Nordisk
Novo Nordisk Stock Falls After Major Rebrand
Read More

Novo Nordisk Stock Falls After Major Rebrand

  • 2026-09-15
This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO) shares fell 2% on Tuesday even after the drugmaker…
NNovo Nordisk
Novo Nordisk Falls 2% as Wegovy Opens a German Front
Read More

Novo Nordisk Falls 2% as Wegovy Opens a German Front

  • 2026-09-08
This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO), the diabetes-and-obesity heavyweight, fell approximately 2% to $46.625 Friday…
NNovo Nordisk
Novo is Down Nearly 2% as a 40.4% Childhood Win Meets Two Trial Cancellations
Read More

Novo is Down Nearly 2% as a 40.4% Childhood Win Meets Two Trial Cancellations

  • 2026-09-07
This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO), the diabetes and obesity-treatment powerhouse, traded at $46.60 Monday,…
NNovo Nordisk
Novo is Down Nearly 2% as a 40.4% Childhood Win Meets Two Trial
Read More

Novo is Down Nearly 2% as a 40.4% Childhood Win Meets Two Trial

  • 2026-09-07
Novo Nordisk NVO, the diabetes and obesity-treatment powerhouse, traded at $46.60 Monday, down nearly 2%, as two clinical…
NNovo Nordisk
Novo Nordisk AS (NVO) Stock Up 3.7% and Still Undervalued -- GF
Read More

Novo Nordisk AS (NVO) Stock Up 3.7% and Still Undervalued — GF

  • 2026-09-07
On September 02, 2026, Novo Nordisk AS NVO shares rose 3.7% today, closing at $46.77. This movement is…
NNovo Nordisk
Novo Nordisk Falls 2% as Wegovy Opens a German Front
Read More

Novo Nordisk Falls 2% as Wegovy Opens a German Front

  • 2026-09-07
Novo Nordisk NVO, the diabetes-and-obesity heavyweight, fell approximately 2% to $46.625 Friday as Wegovy’s pill rollout reached its…
NNovo Nordisk
Novo Nordisk Falls 2% as Wegovy Opens a German Front
Read More

Novo Nordisk Falls 2% as Wegovy Opens a German Front

  • 2026-09-05
This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO), the diabetes-and-obesity heavyweight, fell approximately 2% to $46.625 Friday…
Denmark
www.europesays.com